Kevin Zhang1, Affan Shoukat2, William Crystal2, Joanne M Langley3, Alison P Galvani2, Seyed M Moghadas4. 1. Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. 2. Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, United States. 3. Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre and Nova Scotia Health Authority, Halifax, Nova Scotia, Canada. 4. Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada.
Abstract
OBJECTIVE: Current COVID-19 guidelines recommend symptom-based screening and regular nasopharyngeal (NP) testing for healthcare personnel in high-risk settings. We sought to estimate case detection percentages with various routine NP and saliva testing frequencies. DESIGN: Simulation modeling study. METHODS: We constructed a sensitivity function based on the average infectiousness profile of symptomatic coronavirus disease 2019 (COVID-19) cases to determine the probability of being identified at the time of testing. This function was fitted to reported data on the percent positivity of symptomatic COVID-19 patients using NP testing. We then simulated a routine testing program with different NP and saliva testing frequencies to determine case detection percentages during the infectious period, as well as the presymptomatic stage. RESULTS: Routine biweekly NP testing, once every 2 weeks, identified an average of 90.7% (SD, 0.18) of cases during the infectious period and 19.7% (SD, 0.98) during the presymptomatic stage. With a weekly NP testing frequency, the corresponding case detection percentages were 95.9% (SD, 0.18) and 32.9% (SD, 1.23), respectively. A 5-day saliva testing schedule had a similar case detection percentage as weekly NP testing during the infectious period, but identified ~10% more cases (mean, 42.5%; SD, 1.10) during the presymptomatic stage. CONCLUSION: Our findings highlight the utility of routine noninvasive saliva testing for frontline healthcare workers to protect vulnerable patient populations. A 5-day saliva testing schedule should be considered to help identify silent infections and prevent outbreaks in nursing homes and healthcare facilities.
OBJECTIVE: Current COVID-19 guidelines recommend symptom-based screening and regular nasopharyngeal (NP) testing for healthcare personnel in high-risk settings. We sought to estimate case detection percentages with various routine NP and saliva testing frequencies. DESIGN: Simulation modeling study. METHODS: We constructed a sensitivity function based on the average infectiousness profile of symptomatic coronavirus disease 2019 (COVID-19) cases to determine the probability of being identified at the time of testing. This function was fitted to reported data on the percent positivity of symptomatic COVID-19patients using NP testing. We then simulated a routine testing program with different NP and saliva testing frequencies to determine case detection percentages during the infectious period, as well as the presymptomatic stage. RESULTS: Routine biweekly NP testing, once every 2 weeks, identified an average of 90.7% (SD, 0.18) of cases during the infectious period and 19.7% (SD, 0.98) during the presymptomatic stage. With a weekly NP testing frequency, the corresponding case detection percentages were 95.9% (SD, 0.18) and 32.9% (SD, 1.23), respectively. A 5-day saliva testing schedule had a similar case detection percentage as weekly NP testing during the infectious period, but identified ~10% more cases (mean, 42.5%; SD, 1.10) during the presymptomatic stage. CONCLUSION: Our findings highlight the utility of routine noninvasive saliva testing for frontline healthcare workers to protect vulnerable patient populations. A 5-day saliva testing schedule should be considered to help identify silent infections and prevent outbreaks in nursing homes and healthcare facilities.
Entities:
Keywords:
COVID-19; case detection; nasopharyngeal; outbreak; saliva; testing
Authors: Chad R Wells; Abhishek Pandey; Seyed M Moghadas; Burton H Singer; Gary Krieger; Richard J L Heron; David E Turner; Justin P Abshire; Kimberly M Phillips; A Michael Donoghue; Alison P Galvani; Jeffrey P Townsend Journal: Commun Med (Lond) Date: 2022-07-09
Authors: Adam Jenney; Doris Chibo; Mitch Batty; Julian Druce; Robert Melvin; Andrew Stewardson; Amanda Dennison; Sally Symes; Paul Kinsella; Thomas Tran; Charlene Mackenzie; Douglas Johnson; Irani Thevarajan; Christian McGrath; Amelia Matlock; Jacqueline Prestedge; Megan Gooey; Janine Roney; Joanne Bobbitt; Sarah Yallop; Mike Catton; Deborah A Williamson Journal: Lancet Reg Health West Pac Date: 2022-07-08
Authors: Bradley W M Cook; Kaitlyn Kobasa; Marielou Tamayo; Natasha Theriault; Diane Gordon Pappas; Steven S Theriault Journal: Diagnostics (Basel) Date: 2022-02-12